Schiff Nutrition International (NYSE: WNI) is reportedly “on the prowl” for new acquisitions after a sale of approximately 25 percent of its shares to TPG Growth, a private equity firm affiliated with TPG Capital of Forth Worth and led by William McGlashan Jr.

McGlashan is familiar to the nutritional supplements industry as a co-founder of Pharmanex Inc. McGlashan will become a member of Schiff’s board along with TPG managing partner Matthew T. Hobart.

Based in Salt Lake City, Utah, Schiff develops, manufactures, markets and distributes branded and private label vitamins, nutritional supplements and nutrition bars in the United States and throughout the world, including recognized brands marketed through mass markets (including club stores) and, to a lesser extent, health food stores.

TPG acquired its shares from Weider Health & Fitness, which before the deal controlled approximately 93% of the company’s voting shares and approximately 53% of all Schiff shares outstanding. Weider Health’s Eric Weider will continue to serve as chairman of the board.

The deal signals a renewed strategy of growth through acquisitions of other companies in the supplements industry. According to recent reports, Schiff has already looked at a number of deals in the market. And their timing seems right, as activity in the industry remains strong, including reported acquisitions by The Carlyle Group of its rival NBTY and ramped-up efforts by strategic buyers such as Nestle, which in September launched Nestle Health Science, committing significant resources to its efforts in this segment.

For more information about the deal and Schiff, click here.